Home / Publication / Clinical Pharmacology Tools and Evaluations to Facilitate Comprehensive Dose Finding in Oncology: A Continuous Risk-Benefit Approach

論文

Clinical Pharmacology Tools and Evaluations to Facilitate Comprehensive Dose Finding in Oncology: A Continuous Risk-Benefit Approach

Author(s): Julie Bullock, Tiffany Lin, Sanela Bilic

Year: 2017年9月15日

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

論文

Powered by Translations.com GlobalLink Web Software

Clinical Pharmacology Tools and Evaluations to Facilitate Comprehensive Dose Finding in Oncology: A Continuous Risk-Benefit Approach

Clinical Pharmacology Tools and Evaluations to Facilitate Comprehensive Dose Finding in Oncology: A Continuous Risk-Benefit Approach

日本における小児・希少疾患領域のドラッグ・ロス解消に向けて

Accelerating Oncology Drug FDA Submission with Project Management Services

モデルを活かした医薬品開発 (MIDD) が医薬品開発の危機的状況をどのように救ったか

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

メルマガ登録

クイックアクセス

ソリューション

お問合せ